Journal of Diabetes Investigation (Dec 2022)
Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes
Abstract
No abstracts available.